Published in Cancer Epidemiol Biomarkers Prev on December 01, 1995
Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res (2009) 1.39
Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research. Carcinogenesis (2012) 1.27
NRF2, cancer and calorie restriction. Oncogene (2010) 1.17
Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol Sin (2009) 1.12
Molecular targets of isothiocyanates in cancer: recent advances. Mol Nutr Food Res (2014) 1.08
Ethnoveterinary medicines used for horses in Trinidad and in British Columbia, Canada. J Ethnobiol Ethnomed (2006) 1.06
Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer Res (2014) 1.02
Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer (2010) 0.99
Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer. Int J Cancer (2009) 0.96
Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model. PLoS One (2012) 0.88
Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms. Biochim Biophys Acta (2014) 0.88
Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ Health Perspect (1997) 0.87
Antioxidant assays - consistent findings from FRAP and ORAC reveal a negative impact of organic cultivation on antioxidant potential in spinach but not watercress or rocket leaves. Food Sci Nutr (2013) 0.86
Urinary isothiocyanate levels and lung cancer risk among non-smoking women: a prospective investigation. Lung Cancer (2010) 0.85
What should we tell prostate cancer patients about (secondary) prevention? Curr Opin Urol (2014) 0.82
Phenolic profile and antioxidant potential of wild watercress (Nasturtium officinale L.). Springerplus (2015) 0.81
In vivo modulation of 4E binding protein 1 (4E-BP1) phosphorylation by watercress: a pilot study. Br J Nutr (2010) 0.80
Modulation of detoxification enzymes by watercress: in vitro and in vivo investigations in human peripheral blood cells. Eur J Nutr (2009) 0.80
Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers. Cancer Prev Res (Phila) (2016) 0.79
Induction of epoxide hydrolase, glucuronosyl transferase, and sulfotransferase by phenethyl isothiocyanate in male Wistar albino rats. Biomed Res Int (2014) 0.77
Nutrigenomic effects of glucosinolates on liver, muscle and distal kidney in parasite-free and salmon louse infected Atlantic salmon. Parasit Vectors (2016) 0.75
Characterization of the watercress (Nasturtium officinale R. Br.; Brassicaceae) transcriptome using RNASeq and identification of candidate genes for important phytonutrient traits linked to human health. BMC Genomics (2016) 0.75
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol (1994) 3.17
Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res (1999) 2.99
Biology and management of bladder cancer. N Engl J Med (1990) 2.60
Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst (1994) 2.50
Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res (1984) 2.41
A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med (1993) 2.28
Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. J Natl Cancer Inst (2001) 2.24
Transperineal magnetic resonance image guided prostate biopsy. J Urol (2000) 2.21
The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens. Cancer (1998) 2.14
Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst (1997) 2.07
Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomarkers Prev (1998) 2.00
Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet (2000) 1.98
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol (2000) 1.86
Detection of exocyclic 1,N2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc Natl Acad Sci U S A (1994) 1.76
Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol (1998) 1.73
Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem (2001) 1.72
Urological complications of cyclophosphamide. J Urol (1989) 1.69
Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol Biomarkers Prev (1999) 1.53
Future prospects in prostate cancer. Prostate (1999) 1.53
Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res (1992) 1.52
Gender differences in smoking and risk for oral cancer. Cancer Res (1996) 1.47
Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res (2000) 1.46
Sonography of the male genital tract. AJR Am J Roentgenol (1989) 1.45
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes. Chem Res Toxicol (2001) 1.44
Review of an 8-year experience with modifications of endoscopic suspension of the bladder neck for female stress urinary incontinence. J Urol (1990) 1.43
Rational approach to evaluation and management of spontaneous perirenal hemorrhage. Surg Gynecol Obstet (1990) 1.42
Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev (1995) 1.42
Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol Biomarkers Prev (2001) 1.41
Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage. Int J Radiat Oncol Biol Phys (1999) 1.39
Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol (1998) 1.39
Short and long-term morbidity of thoracoabdominal incision for nephrectomy: a comparison with the flank approach. J Urol (1999) 1.39
Mentholated cigarettes and smoking habits in whites and blacks. Tob Control (2002) 1.37
Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol Biomarkers Prev (1999) 1.35
Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues. Cancer Res (1996) 1.32
Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr Cancer (2000) 1.31
Induction of liver tumors in F344 rats by crotonaldehyde. Cancer Res (1986) 1.30
The determination of glutathione, cyst(e)ine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal Biochem (1987) 1.29
Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev (1997) 1.27
Testicular self-examination. N Engl J Med (1980) 1.27
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol (2001) 1.27
1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. Cancer Res (1998) 1.25
Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res (1996) 1.23
Blood glutathione concentrations in a large-scale human study. Clin Chem (1996) 1.23
Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res (1989) 1.22
Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem Res Toxicol (1991) 1.21
High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate. Anal Biochem (2001) 1.20
Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice. Carcinogenesis (1993) 1.18
Subcapsular hematoma of the liver. Nonoperative management. Arch Surg (1972) 1.17
Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol (1998) 1.16
Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis (1989) 1.16
Life span profiles of glutathione and acetaminophen detoxification. Drug Metab Dispos (1991) 1.15
Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer. J Urol (2011) 1.14
Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol (2001) 1.14
Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol (1995) 1.13
Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst (1993) 1.12
Aggressive surgical approach to renal cell carcinoma: review of 130 cases. J Urol (1979) 1.12
Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol (2000) 1.11
CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev (1997) 1.10
Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res (1980) 1.09
Urologic complications of appendicitis. Urology (1975) 1.09
Results of inferior vena cava resection for renal cell carcinoma. J Urol (1981) 1.09
1,N2-ethenodeoxyguanosine as a potential marker for DNA adduct formation by trans-4-hydroxy-2-nonenal. Cancer Res (1988) 1.08
Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. Int J Radiat Oncol Biol Phys (1999) 1.08
Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol Biomarkers Prev (1996) 1.08
Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res (1989) 1.08
Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma. J Urol (1984) 1.07
Changing concepts in the treatment of nonseminomatous germ cell tumors of the testis. J Urol (1984) 1.07
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials. J Clin Oncol (2000) 1.07
Effects of alkyl chain length on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates. Carcinogenesis (1989) 1.05
Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics (2000) 1.05
Ureteral obstruction secondary to metastatic tumors. Surg Gynecol Obstet (1979) 1.04
Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA (1983) 1.04
Urinary diversion: the physiological rationale for non-refluxing colonic conduits. Br J Urol (1975) 1.03
Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res (1994) 1.03
Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology (1998) 1.02
Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res (1990) 1.02
Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer (1989) 1.01
Formation of cyclic 1,N2--adducts by reaction of deoxyguanosine with alpha-acetoxy-N-nitrosopyrrolidine, 4-(carbethoxynitrosamino)butanal, or crotonaldehyde. Cancer Res (1983) 1.00
Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J Urol (1994) 0.99
Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats. Drug Metab Dispos (1999) 0.99
Incidentally discovered mass of the adrenal gland. Surg Gynecol Obstet (1986) 0.99
The effects of various indwelling ureteral catheter materials on the normal canine ureter. J Urol (1988) 0.98
Carcinoma of the adrenal cortex. Cancer (1980) 0.98
Computerized tomography: how accurate for abdominal staging of testis tumors? J Urol (1982) 0.98
Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco. Tob Control (2008) 0.98
Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal. Cancer Res (1991) 0.97
Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology. AJR Am J Roentgenol (1985) 0.97
Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues. Carcinogenesis (2000) 0.97
Inhibition of rat liver cytochrome P450 isozymes by isothiocyanates and their conjugates: a structure-activity relationship study. Carcinogenesis (1996) 0.97
The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996. Cancer (1999) 0.97
Urologic complications in 718 renal transplant patients. Surgery (1984) 0.97